# Alexander Glaros, M.D. – FDA 483, Jul 17, 2026

Source: https://www.keypedia.com/records/483/alexander-glaros-md/6afd8208-5020-4155-baab-609012316491

> FDA 483 for Alexander Glaros, M.D. on July 17, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alexander Glaros, M.D.
- Inspection Date: 2026-07-17
- Product Type: drugs
- Office Name: Detroit District Office
- Summary: An FDA inspection of Alexander Glaros, M.D. in Detroit, MI, revealed significant deviations in the conduct of a clinical investigation. The firm failed to ensure that study subjects met protocol-required eligibility criteria, and their eligibility was not consistently verified throughout study participation. This indicates a serious lapse in adherence to the investigational plan and investigator responsibilities.

## Related Officers

- [Jason Woodward](https://www.keypedia.com/people/jason-woodward/55659b3f-ce3b-4f6e-b411-6323729c2aee)
- [investigator](https://www.keypedia.com/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)

Company: https://www.keypedia.com/companies/alexander-glaros-md/2ec67c73-6088-4aa4-8d71-7be144028dfb

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03